Target intelligence / Profile preview

Trafficking protein particle complex subunit 12 (TRAPPC12)

Target
TRAPPC12
Molecular classification
Protein complex subunit, Trafficking protein particle complex (TRAPP) component, Tetratricopeptide repeat (TPR) domain-containing protein
01

Overview

Trafficking protein particle complex subunit 12 (TRAPPC12) is an essential subunit of the TRAPPIII complex, which modulates COPII vesicle assembly at endoplasmic reticulum (ER) exit sites to ensure efficient transport from the ER to the Golgi. It is also enriched in the ER–Golgi intermediate compartment. Beyond its central role in vesicle trafficking, TRAPPC12 directly participates in chromosome congression, kinetochore assembly, and recruitment of CENP-E during mitosis. Mutations in TRAPPC12 disrupt Golgi organization, delay ER-to-Golgi protein trafficking, and cause defects in mitotic progression, as well as ciliogenesis, contributing to the development of severe childhood encephalopathy with a constellation of neurodevelopmental deficits. TRAPPC12 is not a classic drug target such as a receptor, enzyme, or transporter, and there are currently no known drugs or targeted mechanisms of action. It is primarily studied for its fundamental roles in cellular trafficking and human neurodevelopmental disease.

Other names
TRAMMTTC15CGI-87PEBASTTC-15TPR repeat protein 15Tetratricopeptide repeat protein 15Tetratricopeptide repeat domain 15trafficking of membranes and mitosis
02

Biological functions

Endoplasmic reticulum to Golgi vesicle-mediated transportPositive regulation of protein localization to kinetochoreRegulation of kinetochore assemblyChromosome congression and mitotic regulationCiliogenesis and cilia disassemblyMembrane trafficking
03

Disease associations

Progressive early-onset encephalopathy with brain atrophy and spasticityEarly-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndromePotential involvement in cancer cell proliferation and apoptosis
04

Safety considerations

Loss of function is linked to severe neurodevelopmental disease (progressive childhood encephalopathy characterized by microcephaly, hearing loss, spasticity, and neuroimaging anomalies)

Beyond the preview

Go deeper on Trafficking protein particle complex subunit 12 (TRAPPC12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trafficking protein particle complex subunit 12 (TRAPPC12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call